Ridgewood Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Ridgewood Investments’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,329	Closed	-$86.7K	–	223
2025 Q2	$86.7K	Hold	1,329	–	–	0.04%	262
2025 Q1	$89K	Hold	1,329	–	–	0.04%	254
2024 Q4	$73.5K	Hold	1,329	–	–	0.04%	267
2024 Q3	$79.3K	Hold	1,329	–	–	0.04%	257
2024 Q2	$84.6K	Buy	+1,329	New	+$86.3K	0.04%	256
2023 Q3	–	Sell	-1,329	Closed	-$71.5K	–	207
2023 Q2	$71.5K	Hold	1,329	–	–	0.04%	277
2023 Q1	$52.8K	Buy	+1,329	New	+$56K	0.03%	328

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return